Treating T2DM and obesity with bariatric surgery and GLP1 agents

Nature Reviews Endocrinology, Published online: 22 July 2019; doi:10.1038/s41574-019-0240-4Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.

Source: Nature Reviews Endocrinology - July 21, 2019 Category: Endocrinology Authors: Clifford J. Bailey Source Type: research